InvestorPlace - Stock Market News, Stock Advice & Trading Tips
CANF stock results show that Can Fite Biofarma beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
The post CANF Stock Earnings: Can Fite Biofarma Beats EPS, Beats Revenue for Q4 2023 appeared first on InvestorPlace.
More From InvestorPlace